Founder of SoftBank-backed Roivant Sciences steps down as CEO

Matt Gline, the founder of SoftBank-backed Roivant Sciences, a biotechnology company, said he will be stepping down from the office of the chief executive officer.

The company’s Chief Financial Officer (CFO) Vivek Ramaswamy will step into the role of executive chairman with Matt Gline assuming the role of the CFO.

In a letter to the company’s shareholders, Ramaswamy said, the move would “separate my increasing public engagement from Roivant’s day-to-day operations”.

Incidentally, Japan’s Sumitomo Dainippon Pharma Co has a 10% stake in Roivant.



Categories: Creativity, Entrepreneurship, HR & Organization, Strategy

Tags: , , , , , , , , , , , , , , ,

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: